Healthtech Pre-Seed Investors & VC Firms
1468 firms in this list, with a median first check of $250K. 393 of them lead rounds. Generated from verified public data and updated continuously.
RDY Ventures
Pre-Seed–Seed$100K – $500K
14 people
Swell Partners
New York CityPre-Seed–Seed$500K – $600K
5 people
Perivoli Innovations
St. HelierPre-Seed–Series A
2 people
DYDX Capital
Redwood CityPre-Seed–Seed
10 people
ATOORO FUND
Tel AvivPre-Seed–Series A$500K – $5M
2 people
Founder One
IstanbulPre-Seed–Seed$100K
6 people
GIMIC Ventures
KarlsruhePre-Seed–Series A$220K – $2.2M
6 people
J4 Ventures
New YorkPre-Seed–Series A
6 people
Mount VC
Grand CaymanPre-Seed–Seed$500K – $640K
6 people
Living Lab Ventures
TangerangPre-Seed–Series A
8 people
Virtue Ventures
AustinPre-Seed–Seed$500K – $2M
2 people
Twin Path Ventures
LondonPre-Seed–Seed$952.5K
4 people
Walking Ventures
LondonPre-Seed–Seed$500K – $1M
4 people
CABHI Ventures
TorontoPre-Seed–Series A
9 people
Failup Ventures
HelsinkiPre-Seed–Seed$200K – $1M
3 people
Impact Ventures
LondonPre-Seed–Series A
12 people
KOI Ventures
Buenos AiresPre-Seed–Seed
15 people
Old Line Capital Partners
BowiePre-Seed–Seed
12 people
Positive Ventures
São PauloPre-Seed–Seed
12 people
āltitude
BerlinPre-Seed–Seed$330K – $540K
8 people
Blindspot Ventures Management Co
BostonPre-Seed–Series B
5 people
Elev8.vc
SingaporePre-Seed–Seed$5M – $15M
5 people
Cambrian Ventures
San FranciscoPre-Seed–Seed$300K – $1M
2 people
Thomas James
Pre-Seed–Series A
2 people
Related lists
Pre-Seed Investors & VC Firms (5569)Healthtech Investors & VC Firms (4190)Healthtech Seed Investors & VC Firms (3233)Pre-Seed Investors & VC Firms in North America (3004)Pre-Seed Investors & VC Firms in United States (2671)Healthtech Investors & VC Firms in North America (2665)Healthtech Investors & VC Firms in United States (2436)Healthtech Series A Investors & VC Firms (2309)AI & Machine Learning Pre-Seed Investors & VC Firms (2102)Fintech Pre-Seed Investors & VC Firms (1711)
Data sourced from public filings and firms' own websites — see our methodology.
























































































